Ticker Details
Anika Therapeutics Inc. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$153.3M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 1.98%
Avg Daily Range (30 D):	$0.15 | 1.52%
Avg Daily Range (90 D):	$0.14 | 1.44%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.12M
Avg Daily Volume (90 D):	.13M

Trade Size
Avg Trade Size (Sh.):	99
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	1,262
Avg Institutional Trade:	$1.25M
Avg Institutional Trade (30 D):	$3.09M
Avg Institutional Trade (90 D):	$1.39M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.19M
Avg Closing Trade (30 D):	$.56M
Avg Closing Trade (90 D):	$.56M
Avg Closing Volume:	33.23K

News

Jan 26, 2026 @ 10:16 PM ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squir... Source: Bragar Eagel & Squire, P.C.

Dec 6, 2025 @ 1:00 AM Anika Therapeutics, Inc. INVESTIGATION: Kirby McIn... Source: Kirby Mcinerney Llp

Sep 25, 2025 @ 9:43 PM ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is... Source: Bragar Eagel & Squire, P.C.

Sep 5, 2025 @ 9:00 AM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Anika Therapeutics, Inc.

Aug 17, 2025 @ 3:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.27	$-.16	$-.28
Diluted EPS	$-2.27	$-.16	$-.28
Revenue	$112.81M	$27.82M	$28.22M
Gross Profit	$61.75M	$15.58M	$14.36M
Net Income / Loss	$-33.04M	$-2.33M	$-3.97M
Operating Income / Loss	$-12.4M	$-3.23M	$-4.18M
Cost of Revenue	$51.05M	$12.23M	$13.86M
Net Cash Flow	$-4.4M	$5.13M	$-.55M
PE Ratio